Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-20.4%
5Y CAGR+8.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-20.4%/yr
vs +32.5%/yr prior
5Y CAGR
+8.7%/yr
Recent deceleration
Acceleration
-52.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $97.31M | -27.9% |
| 2024 | $134.92M | -27.9% |
| 2023 | $187.17M | -3.0% |
| 2022 | $193.00M | +70.9% |
| 2021 | $112.90M | +76.0% |
| 2020 | $64.15M | +7.6% |
| 2019 | $59.63M | -4.7% |
| 2018 | $62.59M | -4.2% |
| 2017 | $65.32M | -3.4% |
| 2016 | $67.62M | - |